Key Dates
|
Symposium dates: 13 - 14 October 2022
Earlybird registration closes: 16 September Final registration closes: 3 October 2022 |
#TAS2022
|
Welcome
On behalf of the organizing committee we are excited to announce the 8th Thomas Ashworth CTC & Liquid Biopsy Symposium 2022 will be held as an in-person even at the UTS Aerial Function Centre, Sydney on the 13 and 14 October 2022. The elevated 7th floor space is a well-designed conference venue located in the vibrant UTS Ultimo precinct close to Central Railway Station. We hope it will inspire both speakers and attendees to engage enthusiastically in the liquid biopsy discussion. In addition, we will be supporting virtual attendance.
The Symposium will run over 2 days enabling us to cover cutting-edge advances in liquid biopsy translational research and clinical practice. The program will begin at 9am on Thursday 13 October and close at 4.30pm on Friday 14 October.
The aim of the Symposium is to enrich our understanding of the clinical application of liquid biopsy to advance precision oncology and improve patient outcome, as well as provide critical insights into the metastatic process and application of liquid biopsy in different contexts. An exciting line up of invited keynote speakers who are leaders in the field, along with invited national speakers from across Australia, will be showcasing their liquid biopsy research.
Topics that will be explored include circulating tumour cells, exosomes, methylated ctDNA, assay development, early detection, integration of liquid biopsy into clinical trials and precision oncology, treatment selection and monitoring as well as drug resistance monitoring.
This year there is also opportunity to submit abstracts for oral and poster presentations. All abstracts will be reviewed be a panel and those chosen for oral presentation will be notified prior to the Symposium. Submissions are welcome from all delegates. Generous prizes will be awarded for the best young investigator oral (rapid fire) and poster presentations - the submission deadline is to Friday 16th September 5pm so please SUBMIT AN ABSTRACT..
Who should attend?
The organising committee maintains a philosophy of keeping registration costs as low as possible to encourage attendance and this is only possible due to the generous support of our sponsors. So please ensure to visit the exhibitor tables and check out their latest product offerings.
We look forward to seeing you at the Symposium in October.
Associate Professor Kevin Spring
Convenor, 8th Thomas Ashworth CTC & Liquid Biopsy Symposium
The Symposium will run over 2 days enabling us to cover cutting-edge advances in liquid biopsy translational research and clinical practice. The program will begin at 9am on Thursday 13 October and close at 4.30pm on Friday 14 October.
The aim of the Symposium is to enrich our understanding of the clinical application of liquid biopsy to advance precision oncology and improve patient outcome, as well as provide critical insights into the metastatic process and application of liquid biopsy in different contexts. An exciting line up of invited keynote speakers who are leaders in the field, along with invited national speakers from across Australia, will be showcasing their liquid biopsy research.
Topics that will be explored include circulating tumour cells, exosomes, methylated ctDNA, assay development, early detection, integration of liquid biopsy into clinical trials and precision oncology, treatment selection and monitoring as well as drug resistance monitoring.
This year there is also opportunity to submit abstracts for oral and poster presentations. All abstracts will be reviewed be a panel and those chosen for oral presentation will be notified prior to the Symposium. Submissions are welcome from all delegates. Generous prizes will be awarded for the best young investigator oral (rapid fire) and poster presentations - the submission deadline is to Friday 16th September 5pm so please SUBMIT AN ABSTRACT..
Who should attend?
- Translational/clinical researchers
- Medical oncologists
- Pathologists
- Clinical trainees, PhD and other students
- Pharmaceutical and diagnostic sector
The organising committee maintains a philosophy of keeping registration costs as low as possible to encourage attendance and this is only possible due to the generous support of our sponsors. So please ensure to visit the exhibitor tables and check out their latest product offerings.
We look forward to seeing you at the Symposium in October.
Associate Professor Kevin Spring
Convenor, 8th Thomas Ashworth CTC & Liquid Biopsy Symposium
Keynote Speakers
Professor Shyamala Maheswaran, PhD
Massachusetts General Hospital Cancer Center, Harvard University , Boston, USA |
A/Professor Jeanne Tie,MBChB, FRACP, MD
Peter MacCallum Cancer Centre, Melbourne, Australia |
Professor Matt Trau, PhD
PUniversity of Queensland, Brisbane, Australia |
A/Professor Anders Skanderup
Genome Institute of Singapore, A*STAR, Singapore |
Platinum Sponsors
|
|
|
Gold Sponsors
|
|
Organizing Committee
A/Prof. Kevin Spring ( Convenor), Ingham Institute, Western Sydney University, Sydney
A/Prof. Therese Becker, Ingham Institute, Sydney
A/Prof. Mark Cowley, Children's Cancer Institute, Sydney
A/Prof. Alex Dobrovic, University of Melbourne, Melbourne
A/Prof. Elin Gray, Edith Cowen University, Perth
Dr. Stephen Wong, Peter MacCallum Cancer Centre, Melbourne
A/Prof. Craig Gedye, Calvary Mater Newcastle & Hunter Medical Research Institute, University of Newcastle, Newcastle
Prof. Chamindie Punyadeera, Griffith University, Brisbane
Prof. Rik Thompson, QUT, Brisbane
Dr Kristina Warton, UNSW, Sydney
For more information please contact A/Prof Kevin Spring - k.spring@westernsydney.edu.au
Copyright 2021 ThomasAshworthSymposium